# Arcadia Biosciences Inc

Arcadia Biosciences Inc is an other based in Davis, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Davis, United States
- **Region:** North America
- **Address:** Davis, CA, United States
- **Founded:** 2002
- **Assets under management:** Undisclosed
- **Website:** arcadiabio.com

## Regulatory record

- **Reports private funds:** No

## About

Arcadia Biosciences was founded in 2002 in Davis, California, initially as a plant-science technology developer. The company went public in 2015 on the Nasdaq under the symbol RKDA. Its wealth came from public market investors rather than a single family fortune. The firm's strategy centers on three core trait platforms: water-use efficiency, nitrogen-use efficiency, and heat tolerance — crops are engineered to yield more grain with less water or fertilizer. Arcadia does not grow or sell grain directly; it licenses its genetics to major seed companies. Known executed license agreements include a pact with Arcadia's former subsidiary, Arcadia Specialty Genomics, and a 2023 partnership with a global seed company for wheat traits. Its geographic focus spans North America, South America, and Australia. As of 2025, Arcadia employed roughly 30 full-time professionals, headquartered in Davis with a small presence in Seattle. In February 2024, the company sold its GoodWheat branded consumer products division as part of a restructuring to focus entirely on its core trait licensing business. A research partnership with the International Rice Research Institute (IRRI) was disclosed in 2023. Arcadia's structural differentiator is its pure-play trait licensing model — the firm does not operate farms, process food, or sell consumer goods. It relies on royalty-based revenue streams, which limits capital intensity but ties cash flow to its partners' adoption rates. The company has self-funded through public equity raises and grant programs, giving it a hybrid public-company governance structure rare among agtech pure plays.

## Sectors

- AgriTech & FoodTech
- ClimateTech
- Industrial Tech

## People

- Stan Jacot — Chief Executive Officer
- Rajiv Gangadharan — Chief Financial Officer

## Questions

### What does Arcadia Biosciences actually do?

Arcadia develops and licenses genetic crop traits that improve water-use efficiency, nitrogen-use efficiency, and heat tolerance in staple crops like wheat and rice. It does not grow or sell grain; it earns revenue through licensing agreements with seed companies worldwide.

### Who are Arcadia's main license partners?

Arcadia has licensed its traits to seed companies operating in North America, South America, and Australia. Specific partners include a global seed company via a 2023 wheat trait agreement and the International Rice Research Institute for rice trait development (per public disclosure, 2023).

### How does Arcadia generate revenue?

The firm earns revenue primarily through upfront license fees, milestone payments, and ongoing royalties on seed sales that incorporate its traits. It has also received grant funding from agencies such as the U.S. Department of Energy.

### Why did Arcadia sell its GoodWheat consumer product line?

In February 2024, Arcadia sold the GoodWheat division to simplify its business model and focus capital on its core trait licensing platform (per the firm's SEC filing, February 2024). The sale effectively ended Arcadia's direct-to-consumer food product operations.

### What is the size of Arcadia's addressable market?

Arcadia targets the global market for wheat and rice seeds — wheat alone is planted on over 500 million acres annually. The firm's traits are designed for large-acre crops, making its royalty potential significant if adoption expands beyond current pilot programs (per the firm's investor materials).

## Related profiles

- [CannaPharmaRx](https://altss.com/profile/cannapharmarx-inc)
- [FendX Technologies](https://altss.com/profile/fendx-technologies-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/arcadia-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
